- Home
- NXL vs AMS Comparison
NXL vs AMS Comparison
Compare NXL & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXL
- AMS
- Stock Information
- Founded
- NXL 2010
- AMS 1980
- Country
- NXL United States
- AMS United States
- Employees
- NXL N/A
- AMS N/A
- Industry
- NXL Medical Specialities
- AMS Medical Specialities
- Sector
- NXL Health Care
- AMS Health Care
- Exchange
- NXL Nasdaq
- AMS Nasdaq
- Market Cap
- NXL 17.8M
- AMS 17.2M
- IPO Year
- NXL 2022
- AMS N/A
- Fundamental
- Price
- NXL $0.93
- AMS $2.56
- Analyst Decision
- NXL Strong Buy
- AMS
- Analyst Count
- NXL 1
- AMS 0
- Target Price
- NXL $5.00
- AMS N/A
- AVG Volume (30 Days)
- NXL 191.8K
- AMS 99.6K
- Earning Date
- NXL 11-07-2025
- AMS 11-12-2025
- Dividend Yield
- NXL N/A
- AMS N/A
- EPS Growth
- NXL N/A
- AMS N/A
- EPS
- NXL N/A
- AMS N/A
- Revenue
- NXL $174,813.00
- AMS $29,251,000.00
- Revenue This Year
- NXL $38.28
- AMS $5.06
- Revenue Next Year
- NXL $185.71
- AMS N/A
- P/E Ratio
- NXL N/A
- AMS N/A
- Revenue Growth
- NXL 16.42
- AMS 26.61
- 52 Week Low
- NXL $0.59
- AMS $2.27
- 52 Week High
- NXL $4.49
- AMS $3.59
- Technical
- Relative Strength Index (RSI)
- NXL 52.06
- AMS 49.43
- Support Level
- NXL $0.86
- AMS $2.41
- Resistance Level
- NXL $0.97
- AMS $3.10
- Average True Range (ATR)
- NXL 0.08
- AMS 0.18
- MACD
- NXL 0.00
- AMS -0.01
- Stochastic Oscillator
- NXL 48.80
- AMS 21.83
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.